UCB SA logo

UCB SA

NEW
OTCPK:UCBJF (Belgium)   Ordinary Shares
$ 191.85 +7.02 (+3.8%) 07:08 PM EST
33.26
P/B:
3.39
Market Cap:
$ 37.54B
Enterprise V:
$ 38.92B
Volume:
200.00
Avg Vol (2M):
800.00
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
200.00
Avg Vol (2M):
800.00

Business Description

Description
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), and Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome).

Financials (Next Earnings Date:2025-07-25 Est.)

UCBJF's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:UCBJF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

UCB SA Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 6,523.678
EPS (TTM) ($) 5.769
Beta 0.48
3-Year Sharpe Ratio 0.57
3-Year Sortino Ratio 0.93
Volatility % 27.47
14-Day RSI 34.29
14-Day ATR ($) 3.734652
20-Day SMA ($) 193.195
12-1 Month Momentum % 61.05
52-Week Range ($) 116.6 - 209.6569
Shares Outstanding (Mil) 190.04

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

UCB SA Filings

Filing Date Document Date Form
No Filing Data

UCB SA Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

UCB SA Frequently Asked Questions

What is UCB SA(UCBJF)'s stock price today?
The current price of UCBJF is $191.85. The 52 week high of UCBJF is $209.66 and 52 week low is $116.60.
When is next earnings date of UCB SA(UCBJF)?
The next earnings date of UCB SA(UCBJF) is 2025-07-25 Est..
Does UCB SA(UCBJF) pay dividends? If so, how much?
The  Dividend Yield %  of UCB SA(UCBJF) is 0.76% (As of Today), Highest Dividend Payout Ratio of UCB SA(UCBJF) was 0.76. The lowest was 0.14. And the median was 0.26. The  Forward Dividend Yield % of UCB SA(UCBJF) is 0.76%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1